HTR2B and amyotrophic lateral sclerosis: Another work by Dentel et al., reported that the spasticity associated with ALS progression couldbe strongly alleviated by the administration of inverse agonists of 5-HT2B/C such as SB206553and Cyproheptadine (both depicted in Figure 12, panels C and D, respectively) [60].